To empower adults who smoke to quit once and for all by combining gold-standard pharmacotherapy with friction-free telehealth, licensed clinical oversight, and compassionate support—delivered entirely online in under five minutes from first click to clinician review.
We envision a future in which quitting tobacco is simpler than buying a pack of cigarettes, where every community—from rural towns to urban centers—is free of the preventable illness, lost productivity, and generational harm caused by nicotine addiction. Qwitly strives to become the globally trusted digital gateway for evidence-based smoking cessation, setting a new standard for accessibility, transparency, and long-term success.
Dr. Safa Rubaye, MD, is a board-certified psychiatrist with 16 years of experience in neuromodulation. Trained at UTHSCSA and the VA PolyTrauma Clinic, he led dementia-biomarker research and treats TBI, PTSD, and co-morbid psychiatric conditions. As faculty at the Texas Institute for Graduate Medical Education and Research, he mentors residents in neuropsychiatry and mental illness care.
Mihir brings a keen eye for detail and expertise in healthcare administration to orchestrate daily operations precisely and streamline clinic workflows. He champions patient advocacy as a vital bridge between our medical team and the community while upholding rigorous standards of care. Dedicated to holistic, patient-centered services, his leadership ensures every decision aligns with our mission, making him indispensable to our success.
Qwitly is a technology platform used by independent, licensed clinicians; it does not itself provide medical advice or dispense medications.